Brought to you by 
LabCorp tenders $302mm offer to acquire women's health diagnostics firm Sequenom
20 Sep 2017
Executive Summary
Laboratory Corp. of America Holdings (LabCorp) entered into a definitive agreement to acquire women's health diagnostics company Sequenom Inc. (non-invasive prenatal testing (NIPT)) in an all-cash tender offer $2.40 per share (a 179% premium), valued at $302mm, over twice Sequenom's 2015 revenues.
Deal Industry
- In Vitro Diagnostics
- Laboratory Testing Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LabCorp tenders $302mm offer to acquire women's health diagnostics firm Sequenom
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice